| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |